Medtronic PLC Company Insiders
| MDT Stock | USD 80.38 0.91 1.12% |
Slightly above 77 percent of Medtronic PLC's insiders are selling. The analysis of insiders' sentiment of trading Medtronic PLC stock suggests that a fairly large number of insiders are terrified at this time. Medtronic PLC employs about 95 K people. The company is managed by 39 executives with a total tenure of roughly 275 years, averaging almost 7.0 years of service per executive, having 2435.9 employees per reported executive.
| Omar Ishrak Chairman Chairman of the Board, Chief Executive Officer |
| Bradley Lerman President Senior Vice President General Counsel, Corporate secretary |
Medtronic PLC's Insider Buying Vs Selling
23
Selling | Buying |
Latest Trades
| 2024-04-08 | Michael Marinaro | Disposed 854 @ 83.14 | View | ||
| 2024-02-21 | Sean Salmon | Disposed 30695 @ 85.13 | View | ||
| 2024-02-09 | Shelley Moore Capito | Disposed @ 84.99 | |||
| 2024-01-23 | Kathy E. Manning | Acquired @ 86.34 | |||
| 2023-12-28 | Jared Moskowitz | Disposed @ 82.74 | |||
| 2023-12-19 | Brett A Wall | Disposed 4997 @ 82.17 | View | ||
| 2023-12-12 | Kathy E. Manning | Disposed @ 80.1 | |||
| 2023-12-05 | Debbie Dingell | Acquired @ 78.82 | |||
| 2023-10-24 | Greg Stanton | Disposed @ 71.96 | |||
| 2023-09-26 | Greg Stanton | Acquired @ 78.96 | |||
| 2023-09-21 | Pete Ricketts | Disposed @ 80.46 | |||
| 2023-08-23 | Gregory L Smith | Disposed 10000 @ 83.84 | View | ||
| 2023-08-14 | Brett A Wall | Disposed 1000 @ 83.38 | View | ||
| 2023-08-07 | Michael Guest | Acquired @ 84.72 | |||
| 2023-08-04 | Michael Marinaro | Disposed 1352 @ 84.11 | View | ||
| 2023-07-14 | Brett A Wall | Disposed 2000 @ 87.97 | View | ||
| 2023-07-10 | Hoedt Rob Ten | Disposed 5514 @ 86.58 | View |
Monitoring Medtronic PLC's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Acquired vs Disposed
Filed vs Not Filed
Insider sentiment refers to the collective sentiment or feeling of Medtronic PLC's insiders - typically its officers, directors, and beneficial owners holding more than a certain percentage of the company's stock - about the future prospects of Medtronic PLC. This sentiment is often gauged based on the trading activities of these insiders. If insiders are purchasing more shares of their own company, it may be interpreted as a bullish sentiment, indicating that they believe Medtronic PLC's stock will rise in value. Conversely, if insiders are selling shares, it might be seen as bearish, suggesting they expect the stock price to drop.
Medtronic |
Medtronic PLC's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Medtronic PLC's future performance. Based on our forecasts, it is anticipated that Medtronic will maintain a workforce of slightly above 95000 employees by May 2024.Medtronic PLC's latest congressional trading
Congressional trading in companies like Medtronic PLC, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Medtronic PLC by those in governmental positions are based on the same information available to the general public.
| 2024-02-09 | Senator Shelley M Capito | Acquired Under $15K | Verify | ||
| 2023-12-28 | Representative Jared Moskowitz | Acquired Under $15K | Verify | ||
| 2023-10-24 | Representative Greg Stanton | Acquired Under $15K | Verify | ||
| 2023-09-21 | Senator John P Ricketts | Acquired $50K to $100K | Verify | ||
| 2023-08-07 | Representative Michael Patrick Guest | Acquired Under $15K | Verify | ||
| 2023-06-15 | Representative Pete Sessions | Acquired $15K to $50K | Verify | ||
| 2023-04-05 | Senator Tina Smith | Acquired $100K to $250K | Verify | ||
| 2022-09-13 | Representative Scott Franklin | Acquired Under $15K | Verify | ||
| 2022-07-29 | Representative Alan S. Lowenthal | Acquired Under $15K | Verify | ||
| 2022-02-18 | Representative Earl Blumenauer | Acquired Under $15K | Verify | ||
| 2022-01-21 | Senator Tommy Tuberville | Acquired $15K to $50K | Verify | ||
| 2020-11-05 | Representative Katherine M. Clark | Acquired Under $15K | Verify | ||
| 2020-11-05 | Senator Bill Cassidy | Acquired Under $15K | Verify | ||
| 2020-04-03 | Representative Peter Welch | Acquired Under $15K | Verify | ||
| 2020-03-18 | Representative Gilbert Cisneros | Acquired Under $15K | Verify | ||
| 2019-06-24 | Representative Donna Shalala | Acquired Under $15K | Verify | ||
| 2018-04-05 | Senator Shelley Moore Capito | Acquired Under $15K | Verify | ||
| 2017-10-24 | Senator William Cassidy | Acquired Under $15K | Verify | ||
| 2017-01-11 | Senator Sheldon Whitehouse | Acquired Under $15K | Verify | ||
| 2016-09-26 | Senator Thomas R. Carper | Acquired Under $15K | Verify |
Medtronic PLC Management Team Effectiveness
The company has Return on Asset of 0.0423 % which means that on every $100 spent on assets, it made $0.0423 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0817 %, implying that it generated $0.0817 on every 100 dollars invested. Medtronic PLC's management efficiency ratios could be used to measure how well Medtronic PLC manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.18 in 2024, whereas Return On Capital Employed is likely to drop 0.05 in 2024. Total Current Liabilities is likely to gain to about 10.9 B in 2024. Liabilities And Stockholders Equity is likely to gain to about 109.8 B in 2024Medtronic PLC Quarterly Income Before Tax |
|
Medtronic PLC Workforce Comparison
Medtronic PLC is considered to be number one stock in number of employees category among related companies. The total workforce of Health Care industry is now estimated at about 95,040. Medtronic PLC totals roughly 95,000 in number of employees claiming about 100% of equities under Health Care industry.
Medtronic PLC Profit Margins
The company has Net Profit Margin of 0.13 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.19 %, which entails that for every 100 dollars of revenue, it generated $0.19 of operating income.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.8 | 0.6519 |
|
| |||||
| Net Profit Margin | 0.14 | 0.1197 |
|
| |||||
| Operating Profit Margin | 0.25 | 0.1489 |
|
| |||||
| Pretax Profit Margin | 0.25 | 0.1293 |
|
| |||||
| Return On Assets | 0.0368 | 0.0387 |
|
| |||||
| Return On Equity | 0.0666 | 0.0701 |
|
|
Medtronic PLC Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Medtronic PLC insiders, such as employees or executives, is commonly permitted as long as it does not rely on Medtronic PLC's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Medtronic PLC insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2024-03-01 | 0.375 | 3 | 8 | 30,695 | 63,112 |
| 2023-12-01 | 0.1667 | 1 | 6 | 1,695 | 8,904 |
| 2023-09-01 | 1.5185 | 41 | 27 | 1,239,904 | 154,497 |
| 2023-06-01 | 0.7143 | 10 | 14 | 18,994 | 16,519 |
| 2022-12-01 | 0.375 | 3 | 8 | 19,035 | 42,453 |
| 2022-09-01 | 2.9 | 29 | 10 | 992,938 | 134,797 |
| 2022-06-01 | 0.75 | 9 | 12 | 15,273 | 41,856 |
| 2022-03-01 | 1.5 | 6 | 4 | 263,528 | 18,441 |
| 2021-12-01 | 0.5833 | 7 | 12 | 114,310 | 109,034 |
| 2021-09-01 | 2.1739 | 50 | 23 | 954,577 | 345,884 |
| 2021-06-01 | 0.7241 | 21 | 29 | 85,734 | 127,976 |
| 2021-03-01 | 1.3333 | 4 | 3 | 30,408 | 14,968 |
| 2020-12-01 | 0.8333 | 20 | 24 | 299,479 | 187,592 |
| 2020-09-01 | 2.3158 | 44 | 19 | 1,544,886 | 118,045 |
| 2020-06-01 | 0.8125 | 13 | 16 | 41,996 | 31,360 |
| 2019-12-01 | 0.4717 | 25 | 53 | 463,606 | 711,951 |
| 2019-09-01 | 0.9318 | 41 | 44 | 1,237,216 | 331,528 |
| 2019-06-01 | 0.88 | 22 | 25 | 79,895 | 139,562 |
| 2019-03-01 | 1.0 | 3 | 3 | 17,671 | 8,227 |
| 2018-12-01 | 2.0 | 2 | 1 | 20,139 | 1,698 |
| 2018-09-01 | 1.2286 | 43 | 35 | 1,398,013 | 674,096 |
| 2018-06-01 | 0.6296 | 17 | 27 | 385,289 | 2,853,878 |
| 2018-03-01 | 0.5 | 7 | 14 | 157,732 | 330,011 |
| 2017-09-01 | 1.5714 | 33 | 21 | 911,933 | 346,551 |
| 2017-06-01 | 1.0909 | 12 | 11 | 28,590 | 13,522 |
| 2017-03-01 | 0.6667 | 12 | 18 | 211,678 | 425,457 |
| 2016-12-01 | 0.6667 | 2 | 3 | 15,660 | 26,773 |
| 2016-09-01 | 1.3514 | 50 | 37 | 1,089,286 | 405,265 |
| 2016-06-01 | 0.8462 | 22 | 26 | 156,455 | 145,741 |
| 2016-03-01 | 0.1667 | 2 | 12 | 324,506 | 676,380 |
| 2015-12-01 | 0.25 | 1 | 4 | 15,401 | 40,665 |
| 2015-09-01 | 2.1333 | 32 | 15 | 839,875 | 145,362 |
| 2015-06-01 | 3.8571 | 27 | 7 | 61,114 | 135,272 |
| 2015-03-01 | 1.8081 | 179 | 99 | 6,014,655 | 1,992,706 |
| 2014-12-01 | 0.3 | 3 | 10 | 2,581 | 89,399 |
| 2014-09-01 | 2.0667 | 31 | 15 | 535,650 | 106,643 |
| 2014-06-01 | 1.8333 | 11 | 6 | 25,489 | 11,004 |
| 2013-12-01 | 1.3333 | 4 | 3 | 99,702 | 40,928 |
| 2013-09-01 | 0.96 | 24 | 25 | 360,989 | 398,990 |
| 2013-06-01 | 1.1875 | 19 | 16 | 204,068 | 378,387 |
| 2012-12-01 | 3.5 | 7 | 2 | 15,566 | 38,196 |
| 2012-09-01 | 2.4 | 12 | 5 | 429,430 | 17,440 |
| 2012-03-01 | 0.75 | 3 | 4 | 59,962 | 118,702 |
| 2011-12-01 | 0.0667 | 1 | 15 | 1,248 | 38,798 |
| 2011-09-01 | 1.2143 | 17 | 14 | 598,918 | 62,618 |
| 2011-06-01 | 9.0 | 9 | 1 | 49,273 | 380.00 |
| 2010-12-01 | 0.25 | 2 | 8 | 101,348 | 39,806 |
| 2010-09-01 | 5.0 | 20 | 4 | 895,815 | 12,364 |
| 2010-06-01 | 4.0 | 20 | 5 | 91,400 | 8,127 |
| 2010-03-01 | 0.6 | 3 | 5 | 43,708 | 11,844 |
| 2009-12-01 | 0.6429 | 9 | 14 | 127,612 | 66,635 |
| 2009-09-01 | 5.3333 | 16 | 3 | 673,724 | 1,085 |
| 2009-06-01 | 5.3333 | 16 | 3 | 40,521 | 7,652 |
| 2008-12-01 | 1.9091 | 21 | 11 | 766,832 | 38,424 |
| 2008-09-01 | 1.3333 | 8 | 6 | 160,896 | 16,205 |
| 2008-06-01 | 1.6111 | 29 | 18 | 143,217 | 141,362 |
| 2008-03-01 | 66.0 | 66 | 1 | 255,093 | 1,504 |
| 2007-12-01 | 1.9167 | 23 | 12 | 607,954 | 61,661 |
| 2007-09-01 | 1.6 | 24 | 15 | 610,305 | 1,020,372 |
| 2007-06-01 | 1.0541 | 39 | 37 | 149,614 | 66,887 |
| 2007-03-01 | 0.4091 | 9 | 22 | 42,773 | 76,943 |
| 2006-12-01 | 1.6667 | 25 | 15 | 666,270 | 198,298 |
| 2006-09-01 | 5.8333 | 35 | 6 | 144,798 | 89,128 |
| 2006-06-01 | 1.2308 | 16 | 13 | 183,923 | 18,197 |
| 2006-03-01 | 1.6667 | 5 | 3 | 23,099 | 33,592 |
| 2005-12-01 | 1.0 | 13 | 13 | 594,379 | 16,345 |
| 2005-09-01 | 2.25 | 27 | 12 | 103,113 | 187,418 |
| 2005-06-01 | 1.0 | 37 | 37 | 387,841 | 526,488 |
| 2005-03-01 | 0.4 | 2 | 5 | 9,776 | 19,552 |
| 2004-12-01 | 0.6 | 15 | 25 | 704,443 | 163,573 |
| 2004-09-01 | 1.9231 | 25 | 13 | 217,468 | 368,876 |
| 2004-06-01 | 1.3571 | 19 | 14 | 129,092 | 11,360 |
| 2004-03-01 | 0.2308 | 3 | 13 | 90,555 | 219,094 |
| 2003-12-01 | 0.6111 | 11 | 18 | 639,406 | 153,766 |
| 2003-09-01 | 15.0 | 30 | 2 | 234,817 | 10,895 |
| 2003-06-01 | 0.0938 | 3 | 32 | 43,992 | 389,797 |
Medtronic PLC Notable Stakeholders
A Medtronic PLC stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Medtronic PLC often face trade-offs trying to please all of them. Medtronic PLC's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Medtronic PLC's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Omar Ishrak | Chairman of the Board, Chief Executive Officer | Profile | |
| Bradley Lerman | Senior Vice President General Counsel, Corporate secretary | Profile | |
| Ryan Weispfenning | Vice President - Investor Relations | Profile | |
| Hooman Hakami | Executive Vice President and Group President of the Medtronic Diabetes Group | Profile | |
| Richard Kuntz | Senior Vice President and Chief Scientific, Clinical and Regulatory Officer | Profile | |
| Robert White | Executive Vice President and President of Medtronic’s Minimally Invasive Therapies Group | Profile | |
| Bryan Hanson | Executive VP and Group President of Minimally Invasive Therapies Group | Profile | |
| Sean Salmon | Executive Vice President and President, Diabetes Operating Unit, President, Cardiovascular Portfolio | Profile | |
| Carol Surface | Chief Human Resource Officer, Senior Vice President | Profile | |
| Karen Parkhill | Chief Financial Officer, Executive Vice President | Profile | |
| Geoff Martha | Executive Vice President and President - Restorative Therapies Group | Profile | |
| Geoffrey Martha | Executive Vice President and President - Restorative Therapies Group | Profile | |
| Robert Hoedt | Executive Vice President and President - EMEA Region | Profile | |
| Michael Coyle | Executive Vice President, Group President - Cardiac and Vascular Group | Profile | |
| Gary Ellis | CFO and Executive VP | Profile | |
| Scott Donnelly | Lead Independent Director | Profile | |
| Richard Anderson | Lead Independent Director | Profile | |
| Elizabeth Nabel | Independent Director | Profile | |
| James Lenehan | Independent Director | Profile | |
| Shirley Jackson | Independent Director | Profile | |
| Preetha Reddy | Independent Director | Profile | |
| Craig Arnold | Independent Director | Profile | |
| Robert Pozen | Independent Director | Profile | |
| Kendall Powell | Lead Independent Director | Profile | |
| Denise OLeary | Independent Director | Profile | |
| Michael Leavitt | Independent Director | Profile | |
| Randall Hogan | Independent Director | Profile | |
| Andrea Goldsmith | Independent Director | Profile | |
| Ivan Fong | General VP | Profile | |
| Brett Wall | Executive Vice President and President Restorative Therapies Group | Profile | |
| Jennifer Kirk | Chief Accounting Officer, Global Controller | Profile | |
| Kenneth Washington | Senior Officer | Profile | |
| Mark Ploof | Senior Services | Profile | |
| Sean Lennon | Chief Officer | Profile | |
| John Liddicoat | Executive Vice President and President Americas Region | Profile | |
| Kevin Lofton | Independent Director | Profile | |
| Sally Saba | Chief Inclusion and Diversity Officer | Profile | |
| Brad Lerman | Senior Vice President General Counsel, Corporate secretary | Profile | |
| MSc MD | Medical Scientific | Profile |
About Medtronic PLC Management Performance
The success or failure of an entity such as Medtronic PLC often depends on how effective the management is. Medtronic PLC management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Medtronic management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Medtronic management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.11 | 0.18 | |
| Return On Capital Employed | 0.05 | 0.05 | |
| Return On Assets | 0.04 | 0.04 | |
| Return On Equity | 0.07 | 0.07 |
The data published in Medtronic PLC's official financial statements usually reflect Medtronic PLC's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Medtronic PLC. For example, before you start analyzing numbers published by Medtronic accountants, it's critical to develop an understanding of what Medtronic PLC's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Medtronic PLC's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Medtronic PLC's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Medtronic PLC's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Medtronic PLC. Please utilize our Beneish M Score to check the likelihood of Medtronic PLC's management manipulating its earnings.
Medtronic PLC Workforce Analysis
Traditionally, organizations such as Medtronic PLC use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Medtronic PLC within its industry.Medtronic PLC Manpower Efficiency
Return on Medtronic PLC Manpower
| Revenue Per Employee | 328.7K | |
| Revenue Per Executive | 800.7M | |
| Net Income Per Employee | 39.8K | |
| Net Income Per Executive | 97M | |
| Working Capital Per Employee | 132.9K | |
| Working Capital Per Executive | 323.7M |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.Note that the Medtronic PLC information on this page should be used as a complementary analysis to other Medtronic PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for Medtronic Stock analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is Medtronic PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medtronic PLC. If investors know Medtronic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medtronic PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.078 | Dividend Share 2.75 | Earnings Share 3.15 | Revenue Per Share 24.298 | Quarterly Revenue Growth 0.047 |
The market value of Medtronic PLC is measured differently than its book value, which is the value of Medtronic that is recorded on the company's balance sheet. Investors also form their own opinion of Medtronic PLC's value that differs from its market value or its book value, called intrinsic value, which is Medtronic PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medtronic PLC's market value can be influenced by many factors that don't directly affect Medtronic PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medtronic PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medtronic PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medtronic PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.